Saliva application in oral and systemic diseases by Yordanova, Mariana Georgieva et al.
Scripta Scientifica Medica, 2018;50(2):13-18
Medical University of Varna 13
REVIEWS
SALIVA APPLICATION IN ORAL AND SYSTEMIC DISEASES
Mariana Yordanova1, Daniela Gerova1, Bistra Galunska2
1Department of General Medicine and Clinical Laboratory,  
Faculty of Medicine, Medical University of Varna 
2Department of Biochemistry, Molecular Medicine and Nutrigenomics,  
Faculty of Pharmacy, Medical University of Varna
Address for correspondence:  
Mariana Yordanova
Faculty of Medicine 
Medical University of Varna
55 Marin Drinov St
9002 Varna
e-mail: m.jordanova.doc@abv.bg
Received: April 1, 2018
Accepted: June 29, 2018
ABSTRACT
Saliva is a noninvasive and accessible biofluid that permits early detection of oral and systemic diseases. 
Changes in saliva reflect the alterations in the blood and thus making saliva a suitable diagnostic tool. The 
use of saliva has many advantages, including simple and non-invasive sampling and easy, low-cost storage. 
Today salivary diagnostics is a promising tool for diagnostic processes and clinical monitoring. Saliva is 
used to detect illicit drugs, alcohol, to measure hormone levels, and in the diagnosis of wide range systemic 
diseases such as cardiovascular, infectious, renal, endocrine diseases, some types of cancer as well as non-
systemic oral diseases.
The current review presents a critical overview of saliva as a promising tool for the development of valuable 
salivary biomarkers, their relevance to the prognosis, diagnosis and management of systemic and oral dis-
eases. Development of point-of-care testing based on saliva samples as a screening tool will also support the 
diagnostic process in near future.
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INTRODUCTION
Saliva is an aqueous slightly acidic (pH 6-7) flu-
id of the oral cavity secreted by several types of sali-
vary glands. The salivary secretions differ consider-
ably in their composition and are affected by differ-
ent physiologic and pathologic factors such as time of 
the day, dietary regimen, age, gender, system or oral 
cavity diseases, and drugs (1). The composition of 
saliva is very complex comprising different in their 
nature secretory products (organic and inorganic). 
These salivary components mostly are ingredients of 
salivary glands secretion, oropharynx and upper air-
way fluids, gastrointestinal reflux fluid, gingival sul-
cus fluid, food deposits in the oral cavity, and blood-
derived compounds.
As a body fluid, saliva plays a very complex bi-
ologic role and supplies a large range of physiologic 
functions. In the oral cavity, saliva is important for 
mastication, normal speech and deglutition func-
tion, gustatory sensitivity, oral cavity lubrication 
and mucosal protection against microbial invasion. 
It takes place in post-eruptive maturation and car-
ioprotection. In the gastrointestinal tract the saliva 
is important for esophageal physiology, enhances the 
digestive process, and contributes to mucosal protec-
tion (2). 
Salivary Composition
Healthy adult subjects normally produce 500–
1500 mL of saliva per day, at a rate of approximate-
ly 0.5 mL/min. Salivary composition and volume can 
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tion collection is usually done using sterile-modi-
fied Carlson–Crittenden/Lashley cup fitted with ap-
propriate polyvinyl chlorate tubing. This device re-
quires suction, which can be provided by a dental 
unit suction, laboratory suction bulb, or oil-free por-
table vacuum pump. Submandibular and sublingual 
secretions can be collected using submandibular and 
sublingual saliva collector fitted with a sterile 100 μL 
pipette tip and a low-affinity plastic conical collec-
tion tube. This device requires suction, which can be 
provided by a dental unit suction or oil-free portable 
vacuum pump (5).
The composition of saliva depends on stimula-
tion: nonstimulated saliva is considered to be a neu-
tral sample, less-affected by salivary glands, while 
stimulated saliva is recommended for a more precise 
detection of cancer biomarkers. A very important is-
sue is the standardization of saliva sample collection 
procedure by taking into account the saliva circadi-
an rhythms and by removing oral stimulants such 
as eating, drinking and oral hygiene practices before 
sample collection (4).
Immediate processing of the sample is recom-
mended in order to avoid decomposition, where this 
is not possible, the sample may be stored at -80ºC. It 
is important to clean and refine the saliva removing 
desquamated epithelial cells, microorganisms and 
remnants of food (4).
Using Saliva as a Diagnostic Fluid
Saliva has been used in diagnostics for many 
years. In ancient traditional Chinese medicine saliva 
and blood are considered ‘brothers’ with a common 
origin and changes in saliva composition are indica-
tive for the patient’s wellness (1).
It is well known that a thin layer of epithelial 
cells separates the salivary ducts from the system-
ic circulation making possible the exchange of sub-
stances between saliva and blood plasma by active 
transport, ultrafiltration or passive membrane diffu-
sion. Therefore, the changes in saliva reflect the alter-
ations in the blood and thus making saliva a suitable 
diagnostic tool (2).
As a diagnostic tool, saliva provides some ad-
vantages over blood serum/plasma related to non-
invasive and simple sample collection not requir-
ing additives such as anticoagulants. Saliva samples 
be affected by various physiological and pathologi-
cal factors including olfactory and gustatory factors, 
chewing process, psychological and hormonal status, 
and drugs. Additionally the age, heredity, oral hy-
giene and physical exercise can also contribute to the 
salivation process (3).
Being an aqueous fluid, the saliva is composed 
of more than 99% water. The inorganic and organic 
part of the saliva reveals wide inter- and intraindi-
vidual variations. The inorganic matter is composed 
mostly of Na+, K+, Cl-, Ca2+, HCO3-, Mg2+, and NH3. 
The organic portion is represented by urea, uric acid, 
creatinine, biogenic amines (putrescine, cadaverine), 
lipids such as cholesterol and fatty acids, and more 
than 400 types of proteins. Most of the proteins are of 
glandular origin (a-amylase, histatins, cystatins, lac-
toferrins, lysozymes, mucins, and proline-rich pro-
teins (PRPs)) or plasma origin (albumin, secretory 
immunoglobulin A, transferrin) (2).
There is a strong relationship between the com-
position and the functions of saliva. For example, the 
a-amylase, mucins and PRPs are related to digestive, 
mastication and deglutition function, lactoferrins, 
lysozymes, and sIgA contribute to the protective and 
defense function.
Collecting Saliva and Sample Handling
The technique of saliva sample taking is one of 
the most important sources of errors affecting the 
final result. Two aspects have to be taken into ac-
count: the type of saliva – whole or gland-specific, 
and the level of secretion stimulation – stimulated or 
nonstimulated.
Studies of oral pathology, salivary gland pa-
thology and systematic diseases most frequently use 
whole saliva, containing fluid from both local and 
systemic sources. Collection of whole saliva samples 
is a simple procedure and requires minimal equip-
ment (4). Passive drool is a saliva collection method 
for collecting whole saliva (also called “mixed” sali-
va). Passive drool is considered to be the gold stan-
dard when collecting saliva samples for biological 
testing, because it provides the purest sample possi-
ble and allows researchers to “biobank” samples for 
future testing. The method ensures rapid sample col-
lection and sample integrity.
There are also established methods for taking 
glandular saliva samples. Ductal and parotid secre-
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are preferable for diagnostics for patients at risk for 
blood sampling such as hemophiliacs (6).
Nowadays saliva samples are used in therapeu-
tic drug monitoring, doping control, steroidal hor-
mones analysis, and in the diagnostics of infection 
diseases. Saliva can potentially be applied in the di-
agnosis of autoimmune, cardiovascular, renal, and 
oral diseases, biomarkers testing for malignancy, fo-
rensic purposes, and psychological research (7).
The usage of saliva as a diagnostic tool is an an-
alytical challenge related to high variability of bioac-
tive compounds in saliva samples and lack of estab-
lished reference values for most of the routine labora-
tory parameters. For each tested systemic biomarker 
a high correlation between saliva and plasma should 
be established. All components produced locally by 
the salivary glands, such as sIgA and lysozyme, re-
veal low plasma levels and can be tested predomi-
nantly in the saliva (3).
1. Infection 
It is considered that saliva is an useful alterna-
tive diagnostic tool for numerous infectious diseases 
such as viral hepatitis, tuberculosis, and Helicobacter 
pylori (HP) infection.
As a diagnostic test saliva can be used for detec-
tion of bacterial and viral pathogens. Usually a com-
bined approach is used measuring both antibody and 
antigen or antibody and nucleic acid in saliva. This 
approach is based on the fact that saliva contains a 
wide spectrum of molecules including immunoglob-
ulins (Ig), and nucleic acids originating from wide 
range viral and microbial pathogens (8).
In the course of hepatitis viral infection IgM, 
IgG, and IgA antibodies are detectable not only in 
serum, but also in saliva. Due to their simplicity of 
sample collection, saliva tests have been reported as 
an alternative to conventional serum testing for hep-
atitis viral infection. However, the sensitivity of de-
tecting hepatitis viral antigens in saliva is 1 to 3 log10 
units lower than that in serum (9).
Therefore, a quantitative DNA/RNA analysis is 
nowadays used for evaluation the hepatitis virus in-
fection (6,10) 
Quantitative DNA analysis is also used for test-
ing Mycobacterium tuberculosis in the saliva. The 
analysis is usually done by the polymerase chain re-
action during the acute phase of the disease when the 
bacterial load is high.
Saliva is also used in the diagnosis of HP infec-
tion as the oral cavity may be a source of infection 
(4). HP is related to a multitude of pathologies such as 
atrophic gastritis, gastric and duodenal ulcers. HP is 
a Gram-negative, microaerophilic bacterium which 
plays an important role in the natural stomach ecolo-
gy. As it binds to salivary mucins MUC-5B and MUC 
7, secreted by the mucous and serous acinar cells of 
the seromucous salivary glands, higher salivary lev-
els of these mucins could be used as indicative bio-
markers for HP infection (8).
2. Malignancy 
Salivary analysis may aid in the early detec-
tion and screening of certain malignant tumors. Sa-
liva also aids in monitoring the efficacy of treatment. 
The well-known serum marker for breast cancer 15-3 
(CA15-3) can also be detected in saliva. Increased lev-
els of CA15-3 were established in the saliva of women 
diagnosed with breast cancer compared to controls. 
In addition, the tumor marker c-erbB-2 (erb), consid-
ered as more robust biomarker of breast cancer than 
CA15-3, was detected in the saliva of breast cancer 
patients and absent in controls (11). Another tumor 
marker found to be elevated in the saliva of women 
with active and nonactive breast cancer is the epider-
mal growth factor.
The cancer antigen CA125 routinely used as a 
serum marker of ovarian cancer, was found to be also 
elevated in the saliva of ovarian cancer patients. It is 
considered that salivary CA125 levels are a better di-
agnostic marker of the disease than the serum val-
ues (12,13).
The tumor suppressor protein p53 is produced 
in a response to various types of DNA damages. In-
activation of p53 by mutations or gene deletions is 
frequently related to cancer development. Antibod-
ies against mutated p53 have been suggested as possi-
ble markers for early diagnosis of oral squamous cell 
carcinoma (OSCC) (14). The p53 antibodies can be 
detected in the saliva of patients diagnosed with oral 
squamous cell carcinoma (1). In a recent study, a sig-
nificantly elevated salivary levels of anti-p53 were es-
tablished in OSCC patients compared to healthy con-
trols. Anti-p53 in saliva can also be used as an early 
marker for OSCC (15). 
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3. Сardiovascular Disease (CVD)
Early diagnosis and early intervention is the 
key for a good CVD patients’ prognosis especially 
in emergent cardiovascular incidents. Saliva is con-
sidered as an ideal fluid for a non-invasive and rapid 
testing with needed analytical and clinical reliabili-
ty that could be used to minimize the time from di-
agnosis to the treatment. The nano-bio-chips (NBC) 
are specific type of point-of-care devices for the 
needs of early diagnosis, periodic monitoring, and 
treatment of disease. The new and sensitive NBC-
based analytical devices are an excellent tool to over-
come the main drawbacks of salivary analysis such 
as low specificity and sensitivity. NBC-based sys-
tem is developed for detection of salivary CRP based 
on antigen and Ab interactions (16). Additionally, a 
multiplex platform “cardiac arrest rapid diagnostic 
information using saliva” (CARDIUS) is developed 
for acute myocardial infarction screening, using an-
tibodies against myoglobin, C-reactive protein, my-
eloperoxidase and IL-1β (17). A disposable electro-
chemiluminescent biosensor was developed for the 
analysis of lactate, marker for acute myocardial in-
farction, using lactate oxidase and luminol based de-
tection system (16.)
For pre- and post-operative control of CVD pa-
tients, salivary alfa-amylase is used as a biomarker. 
A study of Adam et al. showed that low levels of sal-
ivary amylase in the preoperative stage of aorta an-
eurysm are associated with increased mortality (18). 
Another salivary enzyme reported to be associated 
with hypertension, a major risk factor for cardiovas-
cular disorders is lysozyme (6).
4. Renal Diseases
Numerous salivary ingredients including corti-
sol, nitrite, uric acid, sodium, chloride, pH, amylase 
and lactoferrin are considered to be associated with 
end-stage renal disease and developed as salivary bio-
markers (19,20). A colorimetric salivary test strips for 
nitrate and uric acid are developed for the establish-
ment of the hemodialysis regimen. Salivary phosphate 
has been successfully used as a clinical biomarker for 
hyperphosphatemia related to cardiovascular compli-
cations in chronic renal failure patients (21).
5. Monitoring Hormone Levels
Salivary analysis can be used as part of en-
docrine function evaluation (22). The steroid hor-
mones, being lipophilic, are usually transported in 
the blood bound to specific proteins such as SHBG 
(sex hormone-binding globulin) and CBG (cortisol-
binding globulin) and to a lesser extent - to albumin. 
The unbound fraction, 1-2% of their total content, is 
considered bioactive, responsible for their physiolog-
ic effects. The salivary steroids are mainly in an un-
bound form. Тhey reflect the plasma concentrations 
of bioactive hormones as the steroid hormone bind-
ing proteins are not found in saliva and salivary al-
bumin concentration is more than 20 times lower 
than that in plasma (23). Currently saliva is used for 
determination of aldosterone, cortisol, cortisone, de-
hydroepiandrosterone, estradiol, estriol, progester-
one, and testosterone levels. Monitoring salivary tes-
tosterone levels may be useful in behavioral studies 
of aggression, depression, abuse, violent and antiso-
cial behavior (1, 3).
6. Drug Monitoring
Saliva is a convenient noninvasive tool for 
screening substance dependency. Currently, sali-
va is used for qualitative analysis of nicotine, can-
nabinoids, cocaine, phencyclidine, lysergic acid di-
ethylamide, marijuana, opioids, barbiturates, diaz-
epines, amphetamines and ethanol. Express saliva-
based tests are developed for detection of the most 
common drugs of abuse and ethanol. These tests are 
used by law enforcement agencies for roadside eval-
uation of alcohol and abuse drug testing and in hos-
pital emergency departments as a rapid means of de-
termining whether impaired consciousness is related 
to alcohol intoxication.
Salivary nicotine testing is useful in monitor-
ing self-reported compliance with smoking cessation 
programs (1).
7. Forensic Evidence
Saliva is also a useful source for biomarker pro-
filing and forensic identification. It can be used in 
bite mark gender determination and in animal bite 
mark analysis (24). DNA and mRNA can be extract-
ed from bite marks, cigarette butts, postage stamps, 
envelopes and other objects, as during the biting pro-
cess, saliva is deposited on the skin or on the object 
surface in enough amount to allow DNA recovering 
and consequent PCR analysis (6).
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8. Oral Diseases
Dental caries, saliva secretion rate and buff-
ering capacity have proven to be sensitive parame-
ters in caries prediction models. High numbers of S. 
mutans and Lactobacillus indicate a shift in oral mi-
croflora from healthy to more cariogenic. Diagnos-
tic kits for S. mutans and Lactobacillus counting and 
salivary buffering capacity are widely used in dental 
practice and can be conducted without laboratory fa-
cilities (6).
Periodontitis, a chronic, inflammatory dis-
ease destructing the supporting tissues of the teeth 
is provoked by pathogenic periodontal microorgan-
isms found in the plaque biofilm and around gingi-
val margins of the teeth (25). Traditionally a plaque 
or pocket samples are used for either anaerobic cul-
turing or DNA-PCR analysis. Ongoing research has 
shown that saliva reveals almost identical results to 
those obtained by plaque or pocket sampling.
Another field of salivary diagnostics is oral can-
cer, increasing nowadays dramatically. Recent stud-
ies have shown that squamous cell carcinoma com-
prises 3% of all malignancies diagnosed in the Unit-
ed States, making it the tenth most common malig-
nancy (26). Salivary RNA biomarkers yield 91% sen-
sitivity and specificity in distinguishing oral squa-
mous cell carcinoma from controls (27,28).
It has been shown that local chronic oral in-
flammation processes may influence various system-
ic diseases such as anemia, gastritis, colitis, athero-
sclerosis and vascular diseases (29). Plaque biofilm 
releases a variety of biologically active products such 
as endotoxins, cytokines and protein toxins from 
Gram-positive and Gram-negative bacteria coloniz-
ing the tooth surface around the gingival margin and 
interproximal areas. These molecules penetrate the 
gingival epithelium and initiate a host response. As a 
result the gingival epithelium produces chemical me-
diators including interleukin–1 beta (IL-1), prosta-
glandins, tumor necrosis factor alpha (TNF-α), and 
matrix metalloproteinases. These products function 
as attractive molecules for the recruitment of neu-
trophils, T-cells, and monocytes. Antibodies specific 
to oral bacteria circulate in the peripheral blood and 
the acute-phase response becomes activated, CRP, fi-
brinogen and complement are produced both by lo-
cal cells and within the liver. These proteins may fur-
ther exacerbate various systemic diseases (30,31).
CONCLUSION
The ongoing development of salivary diagnos-
tics and the ease of collection of saliva shift the par-
adigm in diagnostic and treatment approaches in 
many areas of medicine and dentistry. Saliva is a use-
ful specimen especially when a qualitative answer 
is required. It can also be used for quantification of 
different analytes when a stable correlation between 
plasma and salivary levels is proved. Used as diag-
nostic aids, salivary biomolecules can identify a va-
riety of cancers, illicit and prescription drug use, he-
reditary disorders and hormonal irregularities.
The development of salivary diagnostics allows 
health professionals early disease prevention, ease 
biomarker monitoring and thus, provides a more 
predictable outcome for the patient.
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